BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 990 filers reported holding BAXTER INTL INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $902 | -36.4% | 23,888 | -23.3% | 0.01% | -9.1% |
| Q2 2023 | $1,419 | +18.9% | 31,152 | +5.9% | 0.01% | -21.4% |
| Q1 2023 | $1,193 | +119.3% | 29,412 | +175.6% | 0.01% | +100.0% |
| Q4 2022 | $544 | -100.0% | 10,671 | -63.0% | 0.01% | -63.2% |
| Q3 2022 | $1,552,000 | -57.7% | 28,815 | -49.5% | 0.02% | -51.3% |
| Q2 2022 | $3,665,000 | +115.8% | 57,059 | +160.5% | 0.04% | +225.0% |
| Q1 2022 | $1,698,000 | -67.8% | 21,901 | -64.4% | 0.01% | -58.6% |
| Q4 2021 | $5,279,000 | -24.9% | 61,496 | -29.6% | 0.03% | -12.1% |
| Q3 2021 | $7,029,000 | -22.7% | 87,389 | -22.7% | 0.03% | -21.4% |
| Q2 2021 | $9,095,000 | +399.2% | 112,981 | +423.0% | 0.04% | +320.0% |
| Q1 2021 | $1,822,000 | -40.5% | 21,604 | -43.4% | 0.01% | -37.5% |
| Q4 2020 | $3,064,000 | +2.6% | 38,188 | +2.9% | 0.02% | -15.8% |
| Q3 2020 | $2,985,000 | +95.4% | 37,113 | +109.1% | 0.02% | +46.2% |
| Q2 2020 | $1,528,000 | -40.2% | 17,748 | -43.6% | 0.01% | -45.8% |
| Q1 2020 | $2,557,000 | +13.6% | 31,496 | +17.0% | 0.02% | +14.3% |
| Q4 2019 | $2,251,000 | +15.7% | 26,916 | +21.0% | 0.02% | +31.2% |
| Q3 2019 | $1,945,000 | -75.3% | 22,240 | -76.8% | 0.02% | -70.4% |
| Q2 2019 | $7,862,000 | +1155.9% | 95,991 | +1146.3% | 0.05% | +800.0% |
| Q1 2019 | $626,000 | -93.8% | 7,702 | -95.0% | 0.01% | -93.2% |
| Q4 2018 | $10,107,000 | +102.1% | 153,557 | +136.7% | 0.09% | +137.8% |
| Q3 2018 | $5,001,000 | +97.1% | 64,868 | +88.8% | 0.04% | +60.9% |
| Q2 2018 | $2,537,000 | -62.0% | 34,360 | -66.5% | 0.02% | -56.6% |
| Q1 2018 | $6,675,000 | -21.6% | 102,626 | -22.1% | 0.05% | -32.9% |
| Q4 2017 | $8,514,000 | -21.3% | 131,707 | -23.6% | 0.08% | -16.8% |
| Q3 2017 | $10,824,000 | +243.3% | 172,495 | +231.2% | 0.10% | +239.3% |
| Q2 2017 | $3,153,000 | -50.7% | 52,077 | -57.8% | 0.03% | -50.9% |
| Q1 2017 | $6,402,000 | +32.7% | 123,450 | +13.5% | 0.06% | +42.5% |
| Q4 2016 | $4,825,000 | +299.1% | 108,812 | +328.3% | 0.04% | +207.7% |
| Q3 2016 | $1,209,000 | -89.7% | 25,406 | -90.2% | 0.01% | -84.3% |
| Q2 2016 | $11,702,000 | -9.7% | 258,776 | -18.0% | 0.08% | -11.7% |
| Q1 2016 | $12,961,000 | +10.3% | 315,513 | +2.5% | 0.09% | +13.3% |
| Q4 2015 | $11,746,000 | +195.1% | 307,890 | +154.1% | 0.08% | +245.8% |
| Q3 2015 | $3,980,000 | -83.2% | 121,156 | -64.2% | 0.02% | -84.6% |
| Q2 2015 | $23,682,000 | +292.7% | 338,651 | +284.6% | 0.16% | +333.3% |
| Q1 2015 | $6,031,000 | -54.0% | 88,046 | -50.8% | 0.04% | -43.8% |
| Q4 2014 | $13,104,000 | +76.7% | 178,795 | +73.0% | 0.06% | +45.5% |
| Q3 2014 | $7,416,000 | -67.4% | 103,330 | -67.1% | 0.04% | -66.7% |
| Q2 2014 | $22,724,000 | +24.9% | 314,305 | +27.1% | 0.13% | +67.1% |
| Q1 2014 | $18,197,000 | -71.4% | 247,310 | -72.9% | 0.08% | -70.2% |
| Q4 2013 | $63,550,000 | +114.4% | 913,728 | +102.5% | 0.26% | +117.2% |
| Q3 2013 | $29,639,000 | +51.9% | 451,189 | +60.2% | 0.12% | +28.4% |
| Q2 2013 | $19,507,000 | – | 281,612 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |